Cell-Free DNA Is Elevated in the Serum of Patients with Hidradenitis Suppurativa

    December 2022 in “ The Journal of Dermatology
    Daniel Johnston, Róisín Hambly, Niamh Kearney, Desmond J. Tobin, Brian Kirby
    TLDR Patients with hidradenitis suppurativa have higher levels of cell-free DNA in their blood.
    This study found that patients with hidradenitis suppurativa (HS) have significantly elevated levels of cell-free DNA in their serum compared to healthy controls. The research involved 20 HS patients, mostly with moderate to severe disease, and 12 healthy individuals. The mean serum level of cell-free DNA in HS patients was 697.4 μg/ml, significantly higher than the 307.8 μg/ml observed in healthy controls (P < 0.0379). Additionally, cell-free DNA levels positively correlated with C-reactive protein (CRP), a marker of inflammation, but not with age or BMI. This suggests that cell-free DNA could be a potential biomarker for HS severity, warranting further investigation in larger studies.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 312 results

      community A concise, easy-to-understand post on Androgenic Alopecia theory and its practical applications

      in Research/Science  92 upvotes 2 years ago
      The mechanism of Androgenic Alopecia and practical applications of treatments like Minoxidil, Finasteride, RU58841, dermarolling, scalp massages, anti-fungals, progesterone, estrogen, PPAR-γ activators, reducing oxidative stress, and scalp exercises. It explains why DHT is important in AA and how other factors might be involved such as hypoxia, increased DKK-1 expression, morphological changes to the scalp, skull growth during childhood/puberty, and blood flow.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

    Similar Research

    5 / 1000+ results